ClinicalTrials.Veeva

Menu

An In-situ Detection for MicroRNA

T

Tongji Hospital

Status

Enrolling

Conditions

Breast Cancer

Treatments

Other: In-situ detection for Micro-RNA

Study type

Observational

Funder types

Other

Identifiers

NCT06529614
20240771

Details and patient eligibility

About

We designed a new in-site detection method for MicroRNA in the serum of patients with breast cancer.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Healthy without serious diseases

-

Exclusion Criteria:

  • situations that may affect the results

Trial design

100 participants in 2 patient groups

Health donor group
Treatment:
Other: In-situ detection for Micro-RNA
Breast cancer group
Treatment:
Other: In-situ detection for Micro-RNA

Trial contacts and locations

1

Loading...

Central trial contact

Lei Dou, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems